CN111296729A - A kind of water-soluble astaxanthin product and preparation method thereof - Google Patents
A kind of water-soluble astaxanthin product and preparation method thereof Download PDFInfo
- Publication number
- CN111296729A CN111296729A CN202010097080.2A CN202010097080A CN111296729A CN 111296729 A CN111296729 A CN 111296729A CN 202010097080 A CN202010097080 A CN 202010097080A CN 111296729 A CN111296729 A CN 111296729A
- Authority
- CN
- China
- Prior art keywords
- astaxanthin
- water
- solution
- whey
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013793 astaxanthin Nutrition 0.000 title claims abstract description 124
- 239000001168 astaxanthin Substances 0.000 title claims abstract description 124
- 229940022405 astaxanthin Drugs 0.000 title claims abstract description 124
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 title claims abstract description 123
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 title claims abstract description 122
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 61
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 61
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000005862 Whey Substances 0.000 claims abstract description 47
- 239000001856 Ethyl cellulose Substances 0.000 claims abstract description 30
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims abstract description 30
- 235000019325 ethyl cellulose Nutrition 0.000 claims abstract description 30
- 229920001249 ethyl cellulose Polymers 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000021119 whey protein Nutrition 0.000 claims abstract description 14
- 238000004108 freeze drying Methods 0.000 claims abstract description 9
- 239000002245 particle Substances 0.000 claims abstract description 8
- 239000007921 spray Substances 0.000 claims abstract description 8
- 238000004945 emulsification Methods 0.000 claims abstract description 6
- 238000007738 vacuum evaporation Methods 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 78
- 238000003756 stirring Methods 0.000 claims description 24
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 239000007764 o/w emulsion Substances 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 239000007762 w/o emulsion Substances 0.000 claims description 10
- 238000009833 condensation Methods 0.000 claims description 5
- 230000005494 condensation Effects 0.000 claims description 5
- 238000002390 rotary evaporation Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract 1
- 238000004062 sedimentation Methods 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000012460 protein solution Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 241000238017 Astacoidea Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000168517 Haematococcus lacustris Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000277331 Salmonidae Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- -1 astaxanthin succinic acid diester Chemical class 0.000 description 1
- 150000001514 astaxanthins Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 238000005354 coacervation Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/90—Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
- A23B2/92—Freeze drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/90—Preservation of foods or foodstuffs, in general by drying or kilning; Subsequent reconstitution
- A23B2/93—Spray drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/04—Solvent extraction of solutions which are liquid
- B01D11/0492—Applications, solvents used
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种水溶性虾青素产品及其制备方法。所述水溶性虾青素产品由虾青素、乳清蛋白、乙基纤维素组成,虾青素含量高于60%,产品颗粒尺寸为微米级。所述制备方法包括如下步骤:将虾青素醇溶液、乙基纤维素醇溶液、乳清溶液按一定比例经分批混合、均质乳化、二次乳化、低温沉降、过滤、低温真空蒸发、喷雾冷冻干燥等处理,制备得到水溶性虾青素。本发明技术有效提高虾青素的水溶性和稳定性,增加虾青素的适用范围,本发明广泛适用于食品、保健品和医药等多个领域。The invention discloses a water-soluble astaxanthin product and a preparation method thereof. The water-soluble astaxanthin product is composed of astaxanthin, whey protein and ethyl cellulose, the content of astaxanthin is higher than 60%, and the particle size of the product is micron. The preparation method comprises the following steps: mixing astaxanthin alcohol solution, ethyl cellulose alcohol solution and whey solution in batches in a certain proportion, homogeneous emulsification, secondary emulsification, low temperature sedimentation, filtration, low temperature vacuum evaporation, The water-soluble astaxanthin is prepared by treatment such as spray freeze-drying. The technology of the present invention effectively improves the water solubility and stability of astaxanthin, and increases the scope of application of astaxanthin.
Description
技术领域technical field
本发明涉及海洋营养素水溶性技术领域,具体涉及一种水溶性虾青素产品及其制备方法。The invention relates to the technical field of water-soluble marine nutrients, in particular to a water-soluble astaxanthin product and a preparation method thereof.
背景技术Background technique
虾青素(3,3′-二羟基-4,4′-二酮基-β,β′-胡萝卜素)是一种脂溶性类胡萝卜色素,分子式为C40H52O4,相对分子质量596.86,不溶于水,易溶于乙醇、丙酮、乙醚和氯仿等大部分有机溶剂。虾青素主要存在于微藻、酵母、鳟鱼、磷虾、虾和小龙虾中,并且雨生红球藻是天然虾青素的丰富来源,虾青素含量高达干物质的6%,被看作天然虾青素的“浓缩品”。Astaxanthin (3,3′-dihydroxy-4,4′-diketo-β,β′-carotene) is a fat-soluble carotenoid with a molecular formula of C40H52O4 and a relative molecular mass of 596.86, insoluble in water , soluble in most organic solvents such as ethanol, acetone, ether and chloroform. Astaxanthin is mainly found in microalgae, yeast, trout, krill, shrimp and crayfish, and Haematococcus pluvialis is a rich source of natural astaxanthin, the content of astaxanthin is as high as 6% of dry matter, which is Considered a "concentrate" of natural astaxanthin.
天然虾青素是一种有效的强抗氧化剂,具有很强的抗氧化性和有效清除体内自由基,防止组织、细胞和DNA被氧化损伤,因而虾青素具有抗氧化、提高免疫力,预防肿瘤、预防心血管疾病和维护眼睛等诸多生理功能,使其逐渐应用于医药、食品、保健品和化妆品等行业且应用前景广阔。Natural astaxanthin is an effective strong antioxidant with strong antioxidant properties and can effectively scavenge free radicals in the body to prevent oxidative damage to tissues, cells and DNA. Therefore, astaxanthin has antioxidant properties, improves immunity, prevents Many physiological functions such as tumor, prevention of cardiovascular disease and maintenance of eyes, etc., make it gradually used in medicine, food, health care products and cosmetics and other industries and have broad application prospects.
虾青素分子结构中具有高度不饱和的共轭双链存在,使其极易被光照、氧气、高温和紫外线照射等发生降解氧化,影响虾青素的稳定性。虾青素难溶于水的性质,使其生物利用度低。可以通过微球技术提高虾青素的水溶性和稳定性。载药微球是指活性成分溶解或者被吸附在高分子基质中形成的微米级球状实体。微球不仅保护芯材活性成分免受环境如氧气、高温和pH等因素的影响,还能提高活性成分的分散性,掩盖不良气味及控制释放,从而提高虾青素产品的商业价值。Astaxanthin has a highly unsaturated conjugated double chain in its molecular structure, which makes it easy to be degraded and oxidized by light, oxygen, high temperature and ultraviolet radiation, which affects the stability of astaxanthin. The insoluble nature of astaxanthin in water makes its bioavailability low. The water solubility and stability of astaxanthin can be improved by microsphere technology. Drug-loaded microspheres refer to micron-sized spherical entities formed by dissolving or adsorbing active ingredients in a polymer matrix. The microspheres not only protect the active ingredients of the core material from environmental factors such as oxygen, high temperature and pH, but also improve the dispersibility of the active ingredients, mask unpleasant odors and control the release, thereby enhancing the commercial value of astaxanthin products.
目前,国内外学者主要通过结构改良、乳化或微胶囊化等方法对虾青素水溶性的改善进行研究。其中,结构改良是通过在虾青素上连接亲水性基团来提高水溶性,公开号为CN105646869A的中国专利公开了水溶性虾青素衍生物及其制备方法,该发明利用虾青素、琥珀酸酐和聚乙二醇(PEG)制备虾青素琥珀酸二酯——PEG衍生物,但这种制备方法在有机溶剂体系中进行,有机溶剂残留,存在安全隐患。公开号CN101297691A的中国专利公开了稳定的水溶性类胡萝卜素干粉的制备方法,该发明将虾青素溶解于丙酮后,再与高于其5倍质量的S-40、阿拉伯胶、β-环糊精、黄原胶和普鲁兰多糖等多种表面活性剂和稳定剂混合,并经喷雾干燥进行制备。该方法主要通过添加稳定剂使虾青素在水中分散,过量使用添加剂不适于加工食品,且存在有机溶剂残留的安全隐患;此外,虾青素在高于100℃时会降解,该发明中使用的喷雾干燥条件不利于虾青素的稳定。公开文献《Physicochemicalproperties of whey-protein-stabilized astaxanthin nanodispersion and itstransport via a Caco-2monolayer》报道了利用分离乳清蛋白作为稳定剂制备虾青素纳米分散体,但其采用的溶剂为丙酮/二氯甲烷混合体系,存在安全隐患,且产品类型不便于运输和保存。公开文献《Astaxanthin from Phaffia rhodozyma:Microencapsulationwith carboxymethyl cellulose sodium and microcrystalline cellulose andeffects of microencapsulated astaxanthin on yogurt properties》报道了利用羧甲基纤维素钠和微晶纤维素作为壁材,通过微胶囊技术来提高虾青素的水溶性,制备产品虾青素含量低,颗粒不均一,应用于食品中容易分层。公开文献《Encapsulation of anastaxanthin-containing lipid extract from shrimp waste by complexcoacervation using a novel gelatinecashew gum complex》报道了利用明胶和腰果胶复合物作为壁材,通过复合凝聚法来提高虾青素的溶解度,但这种制备方法得到的虾青素产品溶解度仅为28.6%,虾青素水溶性低。公开文献《Potato protein-based carriersfor enhancing bioavailability of astaxanthin》报道了用马铃薯蛋白作为载体来改善虾青素的溶解性,但这种制备方法需要对马铃薯蛋白溶液透析一周,耗时长,生产过程也较复杂。因此,有必要研究可行性高、简单有效的方法用于提高虾青素的水溶性。At present, scholars at home and abroad mainly study the improvement of the water solubility of astaxanthin by means of structural improvement, emulsification or microencapsulation. Among them, the structural improvement is to improve water solubility by connecting hydrophilic groups on astaxanthin. The Chinese Patent Publication No. CN105646869A discloses water-soluble astaxanthin derivatives and preparation methods thereof. The invention utilizes astaxanthin, Succinic anhydride and polyethylene glycol (PEG) are used to prepare astaxanthin succinic acid diester, a PEG derivative, but this preparation method is carried out in an organic solvent system, and the organic solvent remains, which has potential safety hazards. The Chinese patent of publication number CN101297691A discloses the preparation method of stable water-soluble carotenoid dry powder. In the invention, after astaxanthin is dissolved in acetone, it is mixed with S-40, gum arabic, β-
发明内容SUMMARY OF THE INVENTION
针对现有技术存在的问题,本发明的目的是提供了一种水溶性虾青素产品及其制备方法。In view of the problems existing in the prior art, the purpose of the present invention is to provide a water-soluble astaxanthin product and a preparation method thereof.
本发明解决上述技术问题的技术方案如下:The technical scheme that the present invention solves the above-mentioned technical problems is as follows:
一种水溶性虾青素产品及其制备方法,其特征在于:产品由以下质量百分比含量的原料:虾青素含量60%~80%,乳清蛋白含量20%~30%,乙基纤维素10%~20%组成;制备方法包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, characterized in that: the product is composed of the following raw materials by mass percentage: astaxanthin content of 60% to 80%, whey protein content of 20% to 30%,
1.虾青素醇溶液和乙基纤维素醇溶液按1:1~2:3混合,经1000rpm~1500rpm转速搅拌10~20min均匀后,以1mL/s速率注入高浓度乳清溶液,持续以1000rpm~1500rpm转速均质乳化5~10min,得到油包水乳液;其中:所述虾青素醇溶液为将虾青素加入无水乙醇,经搅拌溶解,配制成质量体积比为、3%~5%的虾青素醇溶液;所述乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌4~5h,配制成质量体积为0.5~1%的乙基纤维素醇溶液;所述高度乳清溶液为将乳清蛋白粉溶于蒸馏水中,搅拌0.5~1h,配制成质量体积比为2%~3%的乳清溶液;所述高度乳清溶液的体积为10~20mL;1. Mix astaxanthin alcohol solution and ethyl cellulose alcohol solution at a ratio of 1:1 to 2:3. After stirring at 1000 rpm to 1500 rpm for 10 to 20 minutes, inject high-concentration whey solution at a rate of 1 mL/s. 1000rpm~1500rpm rotating speed is homogeneously emulsified for 5~10min to obtain a water-in-oil emulsion; wherein: the astaxanthin alcohol solution is to add astaxanthin into absolute ethanol, stir and dissolve, and prepare a mass-volume ratio of 3%~ 5% astaxanthin alcohol solution; the ethyl cellulose alcohol solution is prepared by adding ethyl cellulose into anhydrous ethanol, and stirring for 4-5 hours to prepare a mass-volume 0.5-1% ethyl cellulose alcohol solution The high whey solution is prepared by dissolving whey protein powder in distilled water, stirring for 0.5 to 1 h, and preparing a whey solution with a mass-to-volume ratio of 2% to 3%; the volume of the high whey solution is 10~10%. 20mL;
2.将低浓度乳清溶液以35~40mL/s速率注入步骤1制得的油包水乳液,同时以1000~1500rpm转速混合,二次乳化5~20min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5~1h,配制成质量体积比为0.1~0.3%的乳清溶液;所述低浓度乳清溶液的体积为180~190mL;水包油乳液中油水相体积比为1:1.9~1:2.1;2. Inject the low-concentration whey solution into the water-in-oil emulsion prepared in step 1 at a rate of 35-40 mL/s, mix at a rotational speed of 1000-1500 rpm, and emulsify twice for 5-20 minutes to obtain an oil-in-water emulsion; The whey solution is to dissolve the whey protein powder in distilled water, stir for 0.5-1 h, and prepare a whey solution with a mass-volume ratio of 0.1-0.3%; the volume of the low-concentration whey solution is 180-190 mL; oil-in-water The volume ratio of oil-water phase in the emulsion is 1:1.9~1:2.1;
3.将步骤2制得的水包油乳液于4℃避光静置12~24h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为35~40℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥6~8h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为62.7~75.9%和42.6~56%。3. Let the oil-in-water emulsion prepared in
上述乳清溶液由乳清蛋白按0.5%~3%的质量体积比加入至一定体积的蒸馏水后,经搅拌0.5~1.0h,配成乳清溶液。The whey solution is prepared by adding whey protein to a certain volume of distilled water at a mass volume ratio of 0.5% to 3%, and stirring for 0.5 to 1.0 hours to prepare a whey solution.
上述水溶性虾青素含虾青素63%,溶解度56%,水溶性虾青素的颗粒尺寸范围280nm~320nm。The above water-soluble astaxanthin contains 63% astaxanthin, has a solubility of 56%, and the particle size of the water-soluble astaxanthin ranges from 280 nm to 320 nm.
本发明所用的乙基纤维素从上海麦克林生化科技有限公司购买,其粘度为45~55mPa.s;本发明所用的虾青素含量为95%。The ethyl cellulose used in the present invention is purchased from Shanghai McLean Biochemical Technology Co., Ltd., and its viscosity is 45-55 mPa.s; the content of astaxanthin used in the present invention is 95%.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
1.本发明提供的一种水溶性虾青素产品及其制备方法,采用两次乳化法制备乙基纤维素-虾青素乳液,减小乙基纤维素在富水相乳液中聚集,从而减小乳液粒径;将乳清蛋白溶液作乳化剂,提高虾青素的分散性和水溶性;喷雾冷冻干燥在低温条件下保持虾青素的功能活性。1. A kind of water-soluble astaxanthin product provided by the invention and preparation method thereof, adopt twice emulsification method to prepare ethyl cellulose-astaxanthin emulsion, reduce the aggregation of ethyl cellulose in the rich water phase emulsion, thereby Reduce the particle size of the emulsion; use the whey protein solution as an emulsifier to improve the dispersibility and water solubility of astaxanthin; spray freeze drying to maintain the functional activity of astaxanthin under low temperature conditions.
2.本发明方法具有可行性强、操作工艺简单、使用食品级有机溶剂、无安全隐患的优点,水溶性虾青素含虾青素62.7%~76.9%,溶解度为42.6%~56%,原料虾青素溶解度11.81%,与原料虾青素相比,水溶性虾青素溶解度明显提高,而且保持虾青素的生物活性,可广泛应用于食品、保健品和医药行业中。2. The method of the present invention has the advantages of strong feasibility, simple operation process, use of food-grade organic solvents, and no potential safety hazards. The solubility of astaxanthin is 11.81%. Compared with the raw material astaxanthin, the solubility of water-soluble astaxanthin is significantly improved, and the biological activity of astaxanthin is maintained. It can be widely used in food, health products and pharmaceutical industries.
附图说明Description of drawings
图1为本发明实施例1所得的虾青素和水溶性虾青素的粒度分布图。1 is a particle size distribution diagram of astaxanthin and water-soluble astaxanthin obtained in Example 1 of the present invention.
图2为本发明实施例1所得的水溶性虾青素产品图。Figure 2 is a product diagram of the water-soluble astaxanthin obtained in Example 1 of the present invention.
图3为本发明实施例1所得的水溶性虾青素在水溶液的分散性图。Fig. 3 is a dispersibility diagram of the water-soluble astaxanthin obtained in Example 1 of the present invention in an aqueous solution.
图4为本发明实施例1所得水溶性虾青素在pH2~pH8水溶液中时贮存3周后的Zeta等电位。4 is the Zeta equipotentiality of the water-soluble astaxanthin obtained in Example 1 of the present invention after storage for 3 weeks in an aqueous solution of pH 2 to pH 8 .
具体实施方式Detailed ways
通过以下实施例和附图对本发明作进一步的说明。The present invention will be further illustrated by the following examples and accompanying drawings.
实施例1Example 1
一种水溶性虾青素产品及其制备方法,包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, comprising the steps:
1.将虾青素醇溶液和的乙基纤维素醇溶液按1:1混合,经1500rpm转速搅拌20min均匀后,以1mL/s速率注入10mL高浓度乳清溶液(质量体积为2%),持续以1500rpm转速均质乳化10min,得到油包水乳液;其中,虾青素醇溶液是将虾青素加入无水乙醇,经搅拌溶解,配成质量体积为5%的虾青素醇溶液;乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌4h,配成质量体积为1%的乙基纤维素醇溶液;高浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为2%的乳清溶液;高浓度乳清溶液的加入体积是10mL;1. Mix the astaxanthin alcohol solution and the ethyl cellulose alcohol solution at 1:1, stir evenly for 20 minutes at 1500 rpm, and inject 10 mL of high-concentration whey solution (2% by mass by volume) at a rate of 1 mL/s, Continue to homogeneously emulsify at 1500 rpm for 10 min to obtain a water-in-oil emulsion; wherein, the astaxanthin alcohol solution is made by adding astaxanthin into absolute ethanol, stirring and dissolving, to prepare a 5% mass/volume astaxanthin alcohol solution; Ethyl cellulose alcohol solution is made by adding ethyl cellulose into absolute ethanol, and stirring for 4 hours to prepare ethyl cellulose alcohol solution with a mass volume of 1%; high-concentration whey solution is to dissolve whey protein powder in distilled water , stir for 0.5h, and prepare a whey solution with a mass-to-volume ratio of 2%; the addition volume of the high-concentration whey solution is 10mL;
2.将低浓度乳清溶液以40mL/s速率注入步骤1制得的油包水乳液,同时以1500rpm转速混合,二次乳化20min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为0.3%的乳清溶液;所述低浓度乳清溶液的体积为190mL;水包油乳液中油水相体积比为1:2;2. The low-concentration whey solution was injected into the water-in-oil emulsion prepared in step 1 at a rate of 40 mL/s, mixed at a speed of 1500 rpm, and emulsified for 20 minutes to obtain an oil-in-water emulsion; the low-concentration whey solution was a mixture of whey The protein powder was dissolved in distilled water, stirred for 0.5 h, and prepared into a whey solution with a mass-volume ratio of 0.3%; the volume of the low-concentration whey solution was 190 mL; the oil-water phase volume ratio in the oil-in-water emulsion was 1:2;
3.将步骤2制得的水包油乳液于4℃避光静置12h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为37℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥7h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为75.9%和56%。3. The oil-in-water emulsion prepared in
实施例2Example 2
一种水溶性虾青素产品及其制备方法,包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, comprising the steps:
1.将虾青素醇溶液和的乙基纤维素醇溶液按2:1混合,经1500rpm转速搅拌20min均匀后,以1mL/s速率注入20mL高浓度乳清溶液(质量体积为3%),持续以1500rpm转速均质乳化10min,得到油包水乳液;其中,虾青素醇溶液是将虾青素加入无水乙醇,经搅拌溶解,配成质量体积为5%的虾青素醇溶液;乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌5h,配成质量体积为0.5%的乙基纤维素醇溶液;高浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为2.5%的乳清溶液;高浓度乳清溶液的加入体积是15mL;1. Mix the astaxanthin alcohol solution and the ethyl cellulose alcohol solution at a ratio of 2:1, stir evenly for 20 minutes at 1500 rpm, and inject 20 mL of high-concentration whey solution (3% by mass by volume) at a rate of 1 mL/s, Continue to homogeneously emulsify at 1500 rpm for 10 min to obtain a water-in-oil emulsion; wherein, the astaxanthin alcohol solution is made by adding astaxanthin into absolute ethanol, stirring and dissolving, to prepare a 5% mass/volume astaxanthin alcohol solution; Ethyl cellulose alcohol solution is made by adding ethyl cellulose into absolute ethanol, and stirring for 5 hours to prepare ethyl cellulose alcohol solution with a mass volume of 0.5%; high-concentration whey solution is whey protein powder dissolved in distilled water , stir for 0.5h, and prepare a whey solution with a mass-to-volume ratio of 2.5%; the added volume of the high-concentration whey solution is 15mL;
2.将低浓度乳清溶液以40mL/s速率注入步骤1制得的油包水乳液,同时以1500rpm转速混合,二次乳化10min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌0.5h,配制成质量体积比为0.3%的乳清溶液;所述低浓度乳清溶液的体积为190mL;水包油乳液中油水相体积比为1:2.1;2. Inject the low-concentration whey solution into the water-in-oil emulsion prepared in step 1 at a rate of 40 mL/s, mix at 1500 rpm, and emulsify twice for 10 minutes to obtain an oil-in-water emulsion; the low-concentration whey solution is a The protein powder was dissolved in distilled water, stirred for 0.5 h, and prepared into a whey solution with a mass-volume ratio of 0.3%; the volume of the low-concentration whey solution was 190 mL; the oil-water phase volume ratio in the oil-in-water emulsion was 1:2.1;
3.将步骤2制得的水包油乳液于4℃避光静置24h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为40℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥8h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为68.7%和53.8%。3. The oil-in-water emulsion prepared in
实施例3Example 3
一种水溶性虾青素产品及其制备方法,包括如下步骤:A water-soluble astaxanthin product and a preparation method thereof, comprising the steps:
1.将虾青素醇溶液和的乙基纤维素醇溶液按2:3混合,经1000rpm转速搅拌10min均匀后,以1mL/s速率注入10mL高浓度乳清溶液(质量体积为2%),持续以1000rpm转速均质乳化5min,得到油包水乳液;其中,虾青素醇溶液是将虾青素加入无水乙醇,经搅拌溶解,配成质量体积为3%的虾青素醇溶液;乙基纤维素醇溶液是将乙基纤维素加入无水乙醇,经搅拌4h,配成质量体积为0.5%的乙基纤维素醇溶液;高浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌1h,配制成质量体积比为3%的乳清溶液;高浓度乳清溶液的加入体积是20mL;1. Mix the astaxanthin alcohol solution and the ethyl cellulose alcohol solution at a ratio of 2:3, stir evenly for 10 minutes at 1000 rpm, and then inject 10 mL of high-concentration whey solution (2% by mass by volume) at a rate of 1 mL/s, Continue to homogeneously emulsify at 1000rpm for 5min to obtain a water-in-oil emulsion; wherein, the astaxanthin alcohol solution is obtained by adding astaxanthin into absolute ethanol, and stirring and dissolving to prepare a 3% mass/volume astaxanthin alcohol solution; Ethyl cellulose alcohol solution is made by adding ethyl cellulose into absolute ethanol, and stirring for 4 hours to prepare a 0.5% ethyl cellulose alcohol solution by mass and volume; high-concentration whey solution is a solution of whey protein powder dissolved in distilled water , stir for 1h, and prepare a whey solution with a mass-to-volume ratio of 3%; the added volume of the high-concentration whey solution is 20mL;
2.将低浓度乳清溶液以35mL/s速率注入步骤1制得的油包水乳液,同时以1000rpm转速混合,二次乳化5min,得到水包油乳液;低浓度乳清溶液是将乳清蛋白粉溶于蒸馏水中,搅拌1h,配制成质量体积比为0.1%的乳清溶液;所述低浓度乳清溶液的体积为180mL;水包油乳液中油水相体积比为1:1.9;2. Inject the low-concentration whey solution into the water-in-oil emulsion prepared in step 1 at a rate of 35 mL/s, mix at a speed of 1000 rpm, and emulsify twice for 5 minutes to obtain an oil-in-water emulsion; the low-concentration whey solution is a mixture of whey The protein powder was dissolved in distilled water, stirred for 1 hour, and prepared into a whey solution with a mass-volume ratio of 0.1%; the volume of the low-concentration whey solution was 180 mL; the oil-water phase volume ratio in the oil-in-water emulsion was 1:1.9;
3.将步骤2制得的水包油乳液于4℃避光静置12h,沉淀过量添加的乙基纤维素和虾青素,经200目纱网筛滤后,经低温真空蒸发去除乙醇,旋蒸温度为35℃,得到虾青素水溶液;将虾青素水溶液进行喷雾冷冻干燥,喷雾冷冻干燥的条件为冷凝温度-40℃,于30℃条件下干燥6h,制得水溶性虾青素产品。产品中虾青素含量和溶解度分别为62.7%和42.6%。3. The oil-in-water emulsion prepared in
实施例1制备的虾青素醇溶液、水溶性虾青素的平均粒径分别为231.7±1.88nm和307.30±11.36nm,具体粒度分布见图1。The average particle diameters of the astaxanthin alcohol solution and the water-soluble astaxanthin prepared in Example 1 are 231.7±1.88nm and 307.30±11.36nm respectively, and the specific particle size distribution is shown in FIG. 1 .
实施例1制备的水溶性虾青素产品见图2。The water-soluble astaxanthin product prepared in Example 1 is shown in Figure 2.
实施例1制备的水溶性虾青素和原料虾青素粉末在水溶液中的分散性见图3。The dispersibility of the water-soluble astaxanthin prepared in Example 1 and the raw material astaxanthin powder in the aqueous solution is shown in Figure 3.
实施例1制备水溶性虾青素在pH2-8范围水溶液贮存3周后水溶性虾青素Zeta电位图见图4。按照表面电荷绝对值≥30mV溶液体系稳定,水溶性虾青素溶液稳定性良好。Example 1 Preparation of water-soluble astaxanthin The Zeta potential diagram of water-soluble astaxanthin after storage in an aqueous solution in the pH range of 2-8 for 3 weeks is shown in FIG. 4 . According to the absolute value of surface charge ≥30mV, the solution system is stable, and the water-soluble astaxanthin solution has good stability.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010097080.2A CN111296729B (en) | 2020-02-17 | 2020-02-17 | Water-soluble astaxanthin product and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010097080.2A CN111296729B (en) | 2020-02-17 | 2020-02-17 | Water-soluble astaxanthin product and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111296729A true CN111296729A (en) | 2020-06-19 |
CN111296729B CN111296729B (en) | 2023-10-03 |
Family
ID=71152891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010097080.2A Active CN111296729B (en) | 2020-02-17 | 2020-02-17 | Water-soluble astaxanthin product and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111296729B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793014A (en) * | 2020-07-27 | 2020-10-20 | 中国海洋大学 | A kind of method for preparing water-soluble astaxanthin and astaxanthin aqueous solution prepared therefrom |
CN113527530A (en) * | 2021-08-06 | 2021-10-22 | 青岛职业技术学院 | Preparation method of water-soluble astaxanthin fucoidin ester |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1656178A (en) * | 2002-05-30 | 2005-08-17 | 化尔氏制药研究公司 | Oil-soluble pigment compositions |
CN104839688A (en) * | 2015-04-20 | 2015-08-19 | 华北制药秦皇岛有限公司 | Eye care preparation and preparation method thereof |
US20150320699A1 (en) * | 2014-05-08 | 2015-11-12 | Yaguang Liu | Pharmaceutical Composition Containing Lutein and Antioxidant for Treating and Preventing Human Disease |
CN105769820A (en) * | 2016-04-08 | 2016-07-20 | 华南理工大学 | Method for preparing astaxanthin sustained release microsphere preparation through supercritical elution technology |
CN105832569A (en) * | 2016-05-31 | 2016-08-10 | 中国农业大学 | Water-dispersible transparent astaxanthin emulsion and preparation method |
CN106172894A (en) * | 2016-07-18 | 2016-12-07 | 马鞍山市黄池食品(集团)有限公司 | A kind of astaxanthin Semen Sesami gel oil and preparation method thereof |
CN108403666A (en) * | 2018-03-16 | 2018-08-17 | 深圳大学 | A kind of preparation method of novel astaxanthin capsule of nano |
CN109198382A (en) * | 2018-07-24 | 2019-01-15 | 湖北工业大学 | A kind of preparation method of water soluble beta-caroten powder |
CN110693945A (en) * | 2019-11-27 | 2020-01-17 | 上海海洋大学 | Astaxanthin self-microemulsion preparation and preparation method and application thereof |
-
2020
- 2020-02-17 CN CN202010097080.2A patent/CN111296729B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1656178A (en) * | 2002-05-30 | 2005-08-17 | 化尔氏制药研究公司 | Oil-soluble pigment compositions |
US20150320699A1 (en) * | 2014-05-08 | 2015-11-12 | Yaguang Liu | Pharmaceutical Composition Containing Lutein and Antioxidant for Treating and Preventing Human Disease |
CN104839688A (en) * | 2015-04-20 | 2015-08-19 | 华北制药秦皇岛有限公司 | Eye care preparation and preparation method thereof |
CN105769820A (en) * | 2016-04-08 | 2016-07-20 | 华南理工大学 | Method for preparing astaxanthin sustained release microsphere preparation through supercritical elution technology |
CN105832569A (en) * | 2016-05-31 | 2016-08-10 | 中国农业大学 | Water-dispersible transparent astaxanthin emulsion and preparation method |
CN106172894A (en) * | 2016-07-18 | 2016-12-07 | 马鞍山市黄池食品(集团)有限公司 | A kind of astaxanthin Semen Sesami gel oil and preparation method thereof |
CN108403666A (en) * | 2018-03-16 | 2018-08-17 | 深圳大学 | A kind of preparation method of novel astaxanthin capsule of nano |
CN109198382A (en) * | 2018-07-24 | 2019-01-15 | 湖北工业大学 | A kind of preparation method of water soluble beta-caroten powder |
CN110693945A (en) * | 2019-11-27 | 2020-01-17 | 上海海洋大学 | Astaxanthin self-microemulsion preparation and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
ACTIVITYDIEGO F. TIRADOA,等: "Astaxanthin encapsulation in ethyl cellulose carriers by continuoussupercritical emulsions extraction: A study on particle size,encapsulation efficiency, release profile and antioxidant activity", 《THE JOURNAL OF SUPERCRITICAL FLUIDS》 * |
SENSOR RESEARCH UNIT,等: "Preventing the thermal degradation of astaxanthin through nanoencapsulation", 《INTERNATIONAL JOURNAL OF PHARMACEUTICS》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111793014A (en) * | 2020-07-27 | 2020-10-20 | 中国海洋大学 | A kind of method for preparing water-soluble astaxanthin and astaxanthin aqueous solution prepared therefrom |
CN111793014B (en) * | 2020-07-27 | 2021-07-13 | 中国海洋大学 | A kind of method for preparing water-soluble astaxanthin and astaxanthin aqueous solution prepared therefrom |
CN113527530A (en) * | 2021-08-06 | 2021-10-22 | 青岛职业技术学院 | Preparation method of water-soluble astaxanthin fucoidin ester |
CN113527530B (en) * | 2021-08-06 | 2022-04-29 | 青岛职业技术学院 | Preparation method of water-soluble astaxanthin fucoidin ester |
Also Published As
Publication number | Publication date |
---|---|
CN111296729B (en) | 2023-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105902401B (en) | A kind of method preparing H- aggressiveness or J- aggressiveness astaxanthin polymer nanometer disperse systems and application | |
CN108403666A (en) | A kind of preparation method of novel astaxanthin capsule of nano | |
Guan et al. | Water-dispersible astaxanthin-rich nanopowder: preparation, oral safety and antioxidant activity in vivo | |
CN105726482A (en) | Xanthophyll nano-liposome and preparation method thereof | |
CN111296729B (en) | Water-soluble astaxanthin product and preparation method thereof | |
CN104337851A (en) | Preparation method of oleum fructus bruceae nano structure lipid carrier and freeze-dried powder thereof | |
CN1698901A (en) | Chitosan or its derivative as drug carrier for carrying red sage root extract | |
CN115364054B (en) | Colon targeting oil-in-water Pickering emulsion based on shellac nano particles and chitosan and preparation and application thereof | |
CN109646425B (en) | Preparation method and application of H1, H2 or J-type astaxanthin aggregate water dispersion system | |
CN101455645A (en) | Preparation method of medicine microspheres using plant soy protein as carrier | |
CN114948880B (en) | Preparation method of caffeic acid phenethyl ester nano stable slow release formulation | |
JP2022545594A (en) | Method for preparing water-soluble astaxanthin complex and astaxanthin aqueous solution prepared thereby | |
CN113797177B (en) | Quercetin oral sustained-release preparation modified by ionic emulsifier chitosan nanoparticles and preparation method thereof | |
Kou et al. | Biodegradable materials as nanocarriers for drugs and nutrients | |
CN113244190A (en) | Astaxanthin long-acting nano preparation prepared by micelle template method and preparation method thereof | |
CN110251487B (en) | Preparation method and application of prolamin nanoparticles for improving docetaxel drug loading and oral bioavailability | |
CN109078184A (en) | Load double medicine nano particles and the preparation method and application thereof | |
CN102048702B (en) | A kind of bifendate nano crystal preparation and preparation method thereof | |
CN111567805A (en) | Water-soluble haematococcus pluvialis astaxanthin soft capsule and preparation method thereof | |
CN1565433A (en) | Hypocrellin water-soluble nanogranule and its uses | |
CN103432083A (en) | Preparation process for glycyrrhizic acid-mediated hydroxycamptothecine albumin liver cancer targeting nanoparticle lyophilized powder | |
CN104434824A (en) | Method for preparing xanthophylls solid dispersion | |
CN114796511A (en) | Mixed solubilizer and preparation method thereof | |
RU2386446C1 (en) | Method for preparing betulin nanosuspension and/or its derivatives | |
CN106377566A (en) | Castor oil and cyclodextrin liquid dispersing agent and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |